From: Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer
Total patients | |
---|---|
No. (%) | |
Gender | |
Female | 16 (17.2%) |
Male | 77 (82.8%) |
Age | |
< 60 years | 75 (80.6%) |
≧ 60 years | 18 (19.4%) |
T classification | |
T1/T2 | 52 (55.9%) |
T3/T4 | 41 (44.1%) |
N classification | |
N0/N1 | 35 (37.6%) |
N2/N3 | 58 (62.4%) |
LVI | |
No | 29 (39.7%) |
Yes | 44 (60.3%) |
PNI | |
No | 15 (18.7%) |
Yes | 65 (81.3%) |
ECE | |
No | 36 (48%) |
Yes | 39 (52%) |
Differentiation | |
Well | 17 (34.7%) |
Moderate/Poor | 32 (65.3%) |
Margin | |
Negative | 41 (45.1%) |
Close/Positive | 50 (54.9%) |
Median RT dose (cGy) | 6600 (range, 600–7000) |
Chemotherapy | |
RT alone | 13 (14%) |
CCRT | 80 (86%) |